Prostamax
Also known as: Lys-Glu-Asp-Pro, KEDP, peptide bioregulator prostamax
Synthetic short-chain oligopeptide bioregulator / epigenetic regulator
What it is
Prostamax is a short peptide studied for prostate health and anti-aging effects, with research suggesting it influences gene activity in aging prostate and immune cells. It is investigated as part of a class of epigenetically active bioregulatory peptides. No FDA-approved use; primarily studied in Russian research with limited independent replication.
The scientific side
Prostamax (Lys-Glu-Asp-Pro) is a short synthetic oligopeptide bioregulator studied primarily for its effects on chromatin structure in aging cells. Published studies report that it promotes decondensation of heterochromatin and deheterochromatinization of facultative chromatin in human lymphocytes from elderly subjects, leading to activation of ribosome genes and release of genes repressed by age-related chromatin condensation. Biophysical studies using differential scanning calorimetry indicate it causes redistribution of thermal energy among chromatin denaturation endotherms and shifts denaturation temperatures to lower values, interpreted as partial relaxation of the 30-nm chromatin fiber. In organotypic tissue culture (rat), a concentration of 0.05 ng/ml showed a stimulating effect on prostate explants compared to controls.
Class: Synthetic short-chain oligopeptide bioregulator / epigenetic regulator
Administration & storage
- Administration
- In vitro cell culture application (PMID: 15085253232211441561255119359734)In vitro organotypic tissue culture application (PMID: 17152728)
- Storage
- No storage conditions for Prostamax are described in the reviewed abstracts.
- Cautions
- All published studies identified in this review are in vitro or ex vivo cell/tissue culture experiments; no human pharmacokinetic, pharmacodynamic, or safety data are available from these abstracts.,No clinical trials, in vivo human dosing studies, or formal toxicology data were identified in the reviewed literature.,Sterile technique is essential for any peptide handling to prevent contamination.,The purity and source of Prostamax used in any preparation should be verified, as research-grade and commercial preparations may differ substantially in quality.
Legal & regulatory status
Not stated in reviewed literature — requires manual verification
Not stated in reviewed literature — requires manual verification
Not stated in reviewed literature — requires manual verification
What it's studied for
- Chromatin decondensation and deheterochromatinization in aging lymphocytes Human observational
- Prostamax induced activation of ribosome genes, decondensation of densely packed chromatin fibrils, and release of age-repressed genes in leukocytes of subjects aged 75–88 years; also caused decondensation of chromosome 1 pericentromeric structural chromatin. PMID 15085253 Lezhava et al., Bulletin of Experimental Biology and Medicine (2004)
- In lymphocytes from individuals aged 75–86 years, Prostamax increased sister chromatid exchange frequency to 12.0±0.28 per cell (vs. 5.9±0.2 in intact cells), increased Ag-positive NORs to 2.5 per cell (vs. 0.95 intact), and reduced large pericentromeric heterochromatin segments on chromosomes 1 and 9, indicating chrom PMID 23221144 Dzhokhadze et al., Georgian Medical News (2012)
- Differential scanning calorimetry showed Prostamax causes redistribution of heat among chromatin denaturation endotherms and shifts both endotherms to lower temperatures by 2.9 and 1.0°C, interpreted as partial relaxation of the 30-nm chromatin fiber and small structural changes in nucleosomal organization. PMID 15612551 Meskhi et al., Biofizika (2004)
- Tissue-specific stimulation of reparative processes in aging prostate tissue Animal studies only
- In organotypic tissue culture of prostate explants from young (3-week) and aged (18-month) Wistar rats, Prostamax at 0.05 ng/ml showed a stimulating effect on prostate tissue compared to control explants in all age groups. PMID 17152728 Zakutskiy et al., Advances in Gerontology (2006)
- Interaction with heavy metal-induced chromatin changes Human observational
- Microcalorimetric study examined joint influence of Prostamax and Cu(II)/Cd(II) ions on chromatin structure in situ in blood lymphocyte cultures from aging individuals. Cu(II) caused additional condensation of heterochromatin; Cd(II) caused decondensation and partial denaturation; Prostamax effects were studied in this PMID 19359734 Kiladze et al., Georgian Medical News (2009)
- Epigenetic regulation and longevity-associated peptide motif identification Animal studies only
- Short-chain epigenetically active peptides with motifs similar to Prostamax were identified in proteins of long-lived African mole rats (Heterocephalus glaber) but not in short-lived Norway rat or house mouse, suggesting a link between such peptide motifs and longevity. PMID 28948547 Khavinson et al., Bulletin of Experimental Biology and Medicine (2017)
Safety signals
- Increased sister chromatid exchange (SCE) frequency observed in lymphocytes treated with Prostamax (SCE increased to 12.0±0.28 per cell from 5.9±0.2 in intact cells). SCE is a marker of DNA strand breakage and repair; the biological significance and safety implications of this increase are not discussed in the abstract. PMID 23221144
Protocol
No community dose for Prostamax on record yet.
All studies (6)
- PMID 15085253 Human observational
Chromatin decondensation and deheterochromatinization in aging lymphocytes - PMID 15612551 Human observational
Chromatin decondensation and deheterochromatinization in aging lymphocytes - PMID 19359734 Human observational
Interaction with heavy metal-induced chromatin changes - PMID 23221144 Human observational
Chromatin decondensation and deheterochromatinization in aging lymphocytes - PMID 17152728 Animal studies only
Tissue-specific stimulation of reparative processes in aging prostate tissue - PMID 28948547 Animal studies only
Epigenetic regulation and longevity-associated peptide motif identification
Frequently asked
What is Prostamax and what is its amino acid sequence?
Prostamax is a synthetic short-chain oligopeptide bioregulator with the sequence Lys-Glu-Asp-Pro (KEDP). It has been studied primarily for its effects on chromatin structure in aging cells.
What has research shown about how Prostamax works?
Published laboratory studies report that Prostamax promotes decondensation of heterochromatin in human lymphocytes from elderly subjects, activates ribosome genes, and releases genes that had been repressed by age-related chromatin condensation — a process called deheterochromatinization. Biophysical studies found it shifts chromatin denaturation temperatures to lower values, interpreted as partial relaxation of the 30-nm chromatin fiber. In rat prostate tissue culture, 0.05 ng/ml stimulated tissue explants compared to controls. These are all laboratory findings; no human clinical trials were identified in the reviewed literature.
Has Prostamax been tested in humans?
The reviewed studies applied Prostamax to cultured human lymphocytes obtained from elderly donors (aged 75–88 years) in vitro — meaning outside the body in laboratory conditions. No clinical trials or in vivo human studies were identified in the reviewed abstracts. No human pharmacokinetic or safety data were found.
What dose of Prostamax should I take?
I'm not a medical professional and can't recommend a protocol for you specifically. What research has shown: The only dose explicitly stated in the reviewed abstracts is 0.05 ng/ml used in an animal organotypic tissue culture experiment. No human dosing data were identified. Human studies applied Prostamax to cell cultures without specifying a dose relevant to human administration.
Can I stack Prostamax with other peptides?
I can't recommend combining compounds — that's a prescribing decision. Here's what has been studied individually: One study compared Prostamax alongside Vilon, Epithalon, Livagen, and Cortagen in the same in vitro lymphocyte experiment, but these were applied separately and no combination protocols were tested or reported.
Where can I buy Prostamax?
I don't recommend vendors or sources. Please consult a licensed provider.
Is Prostamax approved by the FDA or legal to use?
The reviewed abstracts do not address FDA approval, regulatory status, or legal classification of Prostamax in any jurisdiction. This requires manual verification with regulatory authorities. Please consult a licensed healthcare provider or relevant regulatory body.
Can Prostamax help with prostate problems or prostate disease?
I can't suggest treatments for medical conditions. Please speak with a licensed healthcare provider. What the reviewed literature reports: One animal study found Prostamax at 0.05 ng/ml had a stimulating effect on prostate tissue explants in organotypic culture compared to controls in both young and aged rats. No human clinical studies on prostate disease were identified in the reviewed abstracts.
Is Prostamax safe? Are there any known side effects?
No formal safety or toxicology studies were identified in the reviewed abstracts. One in vitro observation noted that Prostamax increased the frequency of sister chromatid exchanges (SCE) in human lymphocytes — a marker of DNA strand breakage/repair events — though the authors did not characterize this as a safety concern. The absence of human in vivo studies means the safety profile in living humans is unknown from the reviewed literature.
Does Prostamax have anti-aging effects?
The reviewed studies were conducted in the context of aging research. In vitro experiments on lymphocytes from elderly humans (75–88 years) showed Prostamax could reverse certain age-associated chromatin changes, such as decondensing heterochromatin and reactivating repressed genes. A separate study identified similar epigenetically active peptide motifs in long-lived African mole rat proteins but not in shorter-lived rodents, contextualizing Prostamax-like peptides in longevity biology. These are laboratory findings only; no controlled clinical anti-aging trials were identified.